GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS (IST:RTALB) » Definitions » Cyclically Adjusted PS Ratio

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) Cyclically Adjusted PS Ratio : 8.67 (As of Jun. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Cyclically Adjusted PS Ratio?

As of today (2024-06-04), RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's current share price is ₺11.27. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was ₺1.30. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio for today is 8.67.

The historical rank and industry rank for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio or its related term are showing as below:

IST:RTALB' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 8.71   Med: 10.49   Max: 14.75
Current: 8.71

During the past years, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's highest Cyclically Adjusted PS Ratio was 14.75. The lowest was 8.71. And the median was 10.49.

IST:RTALB's Cyclically Adjusted PS Ratio is ranked worse than
62.9% of 504 companies
in the Biotechnology industry
Industry Median: 5.525 vs IST:RTALB: 8.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's adjusted revenue per share data for the three months ended in Sep. 2023 was ₺0.193. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₺1.30 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Cyclically Adjusted PS Ratio Historical Data

The historical data trend for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Cyclically Adjusted PS Ratio Chart

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 13.71

Competitive Comparison of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio falls into.



RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=11.27/1.3
=8.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.193/129.8595*129.8595
=0.193

Current CPI (Sep. 2023) = 129.8595.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 98.326 0.000
201403 0.101 99.695 0.132
201406 0.040 100.560 0.052
201409 0.133 100.428 0.172
201412 0.118 99.070 0.155
201503 0.133 99.621 0.173
201506 0.143 100.684 0.184
201509 0.138 100.392 0.179
201512 0.159 99.792 0.207
201603 0.135 100.470 0.174
201606 0.125 101.688 0.160
201609 0.107 101.861 0.136
201612 0.175 101.863 0.223
201703 0.155 102.862 0.196
201706 0.183 103.349 0.230
201709 0.142 104.136 0.177
201712 0.174 104.011 0.217
201803 0.092 105.290 0.113
201806 0.073 106.317 0.089
201809 0.056 106.507 0.068
201812 0.113 105.998 0.138
201903 0.095 107.251 0.115
201906 0.060 108.070 0.072
201909 0.058 108.329 0.070
201912 0.049 108.420 0.059
202003 0.258 108.902 0.308
202006 0.571 108.767 0.682
202009 0.481 109.815 0.569
202012 1.124 109.897 1.328
202103 0.622 111.754 0.723
202106 0.870 114.631 0.986
202109 1.120 115.734 1.257
202112 1.182 117.630 1.305
202203 1.010 121.301 1.081
202206 0.251 125.017 0.261
202209 0.164 125.227 0.170
202212 0.011 125.222 0.011
202303 0.151 127.348 0.154
202306 0.171 128.729 0.173
202309 0.193 129.860 0.193

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS  (IST:RTALB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) Business Description

Traded in Other Exchanges
N/A
Address
Plastikciler Organize Sanayi Bolgesi (GEPOSB), Cumhuriyet Cad. No:3, Kocaeli, Gebze, TUR, 41400
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS is engaged in research, development, and production of Vitro diagnostics. The company offers Real-Time PCR Kits, Nucleic Acid Isolation Kits, and DNA qPCR Probe Master Mix Kit.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) Headlines

No Headlines